Sarah Omachi’s Post

In this Healio Exclusive, we are talking about #IBS! 🚽 What types of #IBS exist and how do you treat it? We asked experts from the field, including: ✅ Lin Chang, MD, from UCLA ✅ William D Chey, MD, AGAF, FACG, FACP, from Michigan Medicine ✅ Anthony Lembo, MD, from the Cleveland Clinic Thank you Edward Loftus for sharing the highlights of the latest #gastroenterology issue! If you are interested in learning more, click here for the full article. ⤵ https://bit.ly/3PvKU4T

Upcoming #webinar alert! ⚠️ This session will provide students with the opportunity to gain a deeper understanding of alternative career paths in behavioral medicine! Register for this insightful webinar now! 🌟https://ow.ly/Etji50Qsz3W

🔬 Exciting News in Medical Research! 🌟 UVA researchers are revolutionizing lung transplants, uncovering key strategies for improved survival rates. Dive into groundbreaking insights and transformative steps in our latest news article. 🚀 Click the link to uncover the secrets behind UVA's transformative approach to lung transplants and how it could shape the future of patient care. https://bit.ly/3tLqwoS Credit: University of Virginia, journal Science Signaling, National Institutes of Health (NIH): Intramural Research Program (IRP) #lungtransplant #organtransplant #NIH #healthscience #meded #eMednews

🌟 On this World Amyloidosis Day, we are proud to highlight Jacquie Baker, recipient of the CCS-Pfizer ATTR-CM 2023 Research Fellowship Award. 🔍 Jacquie is a postdoctoral associate at the Cumming School of Medicine in Calgary where she is studying the impact of autonomic health on #amyloidosis patients. When the autonomic nervous system is impaired, it can cause symptoms like lightheadedness, dizziness, difficulty regulating body temperature, and problems with blood pressure control. These challenges can impact daily activities, independence, and overall quality of life for patients. 💡 We are proud to support researchers like Jacquie and partner with organizations such as the Canadian Cardiovascular Society. Through our collective efforts, we aim to enhance understanding, improve patient outcomes, and make a positive impact on the lives of amyloidosis patients and their loved ones! To learn more about Jacquie’s project visit: https://lnkd.in/evwNuHDt 🙌 💙 #WorldAmyloidosisDay #ResearchMatters #ImprovingPatientCare

Gain insight into designing for expanded realities with a behind-the-scenes look into Stanford University's first-ever class on psychedelic medicine at #SXSW. Browse more sessions in the #Psychedelics track to add to your schedule. https://ow.ly/vf4J50Qtov3

In honor of Healthy Vision Month, we’re highlighting a recent discovery in vision loss prevention from UVA Health School of Medicine scientists. Ambati Jayakrishna, MD, Shao-bin Wang, PhD, and colleagues have identified a potential new target to prevent the formation of abnormal tangles of blood vessels. Abnormal vessel overgrowth is typically associated with vision impairment and eye conditions such as neovascular age-related macular degeneration. Ambati and Wang’s new research not only deepens the medical community’s current understanding of vision loss but also opens possibilities for cost-effective and accessible treatments, avoiding drug resistance concerns found in conventional anti-VEGF therapies. Read their overview here: https://loom.ly/8VEf5DA - #VCCRN #clinicalresearch #visionhealth #clinicalbreakthrough

I am so proud of my PhD student Andreas Kirknaes Faerk for successfully presenting the first exciting results from our randomized, controlled trial of cognitive rehabilitation in multiple sclerosis at this year's ECTRIMS congress. The results are perfectly aligned with the trajectory of the MS research. We need to investigate methods for improving or delaying worsening of symptoms that affect so many patients and severely impact the quality of life and personal independence. I look forward to more results from this trial, which is so close to my heart! #ECTRIMS2024 #cognitiverehabilitation #cognitiveimpairment #multiplesclerosis

Launching the future of medicine Population omics is designed to integrate new omics methodologies along with electronic health records, enabling clinicians and researchers to collaborate in multidisciplinary teams to advance patient care. It is a key component of a four-part omics strategy. "These four interconnected omics pillars will accelerate and magnify our impact, drive scientific advancements in individualized medicine and, ultimately, improve patient care," says Dr. Lazaridis. "This ambitious framework underscores Mayo Clinic's commitment to pioneering the omics era so that personalized medicine can benefit everyone." #FutureOfMedicine #PopulationOmics #PersonalizedMedicine #PatientCareInnovation #HealthcareInnovation #OmicsStrategy #MultidisciplinaryCollaboration #MayoClinicResearch

🗣️ We are extcited to share our new scoping review on #cramps and #spasms in individuals with #spasticity 👉 Cramps and spasms probably represent similar symptoms with partly overlapping pathphysiology 👀 Clinicians must consider that part of the patient’s spams may be attributed to cramps 💊Cramps may be an underestimated - and potentially mistreated phenomenon - in spasticity. Frontiers ⬇️ https://lnkd.in/dNKWNmut 🙌🏽 Pernille Kaster and Jens Bo Nielsen Faculty of Health and Medical Sciences, UCPH

Join me learning more from James on Perlecan in Cardiomyocyte development, and how he utilized the #denovoMATRIX to understand the role of the ECM in that.